The relationship between HIV/AIDS and coronary heart disease: A bibliometric analysis

Qiong Cai,Wei Pan,Chunming Zhang,Xianhui Zhang,Chunjie Wang,Yan Sun,Mingyang An,Fang Pan,Jiangping Xiao,Xilong Pan
DOI: https://doi.org/10.1097/md.0000000000039831
IF: 1.6
2024-10-09
Medicine
Abstract:Acquired immunodeficiency syndrome (AIDS) is a disease caused by human immunodeficiency virus (HIV) infection that severely impairs the function of the immune system. CD4 + T-lymphocyte count is the leading indicator of the stage of HIV infection and the effectiveness of treatment. [ 1 ] Antiretroviral therapy (ART) is an effective method to inhibit HIV replication and reinvigorate the immune system. [ 2 ] The Joint United Nations Programme on HIV/AIDS estimates that in 2022. In the world, 39 million people living with HIV (PLHIV) and 29.8 million PLHIV are on ART. [ 3 ] Although ART effectively reduces the harm associated with HIV infection, it doubles the risk of cardiovascular disease in PLHIV. [ 4–6 ] After receiving ART, PLHIV generally have vascular inflammation, [ 7 , 8 ] insulin resistance, [ 9 ] dyslipidemia, [ 9 , 10 ] increased visceral adipose tissue, [ 11 ] and immune activation, [ 6 ] which will increase the risk of coronary heart disease (CHD). Compared with people without HIV, PLHIV are more likely to have heart failure [ 12 ] and have higher intramyocardial triglyceride content. [ 13 ] Intramyocardial triglyceride content is one of the significant factors contributing to the increased risk of CHD.
medicine, general & internal
What problem does this paper attempt to address?